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doi:10.1016/j.jtcvs.2007.05.009bjective: Mitochondrial permeability transition pore opening plays a critical role in
ediating the mitochondrial response to ischemia/reperfusion injury and initiation
f apoptosis. We tested whether inhibition of mitochondrial permeability transition
ore opening with cyclosporine A prevented apoptosis-related alterations in mito-
hondrial structure and function after cardioplegic arrest.
ethods: Newborn piglets (age 14 days) underwent cardiopulmonary bypass,
ardioplegic arrest (60 minutes), weaning from bypass, and 6-hour reperfusion.
omparison was made among cold crystalloid cardioplegia (n 5), cold crystalloid
ardioplegia with cyclosporine A pretreatment (n  5), and noncardiopulmonary
ypass (n  5) groups.
esults: Early apoptosis signaling events (Bax translocation to the mitochondria)
ere prominent in cold crystalloid cardioplegia and prevented in cold crystalloid
ardioplegia  cyclosporine A myocardium. Mitochondrial release of cytochrome
, determined by Western blot of cytosolic fractions and confocal quantitative
olocalization analysis, was also prominent in cold crystalloid cardioplegia but
revented in cold crystalloid cardioplegia  cyclosporine A myocardium. Electron
icroscopy of isolated mitochondria demonstrated subjective alterations in mito-
hondrial architecture in cold crystalloid cardioplegia mitochondria, which were
revented by cyclosporine A. Deficiency of isolated mitochondrial oxygen con-
umption at Complex I was present in cold crystalloid cardioplegia mitochondria
nd prevented by cyclosporine A (P  .01). The frequency of deoxyuride-5=-
riphosphate biotin nick end labeling-positive myocytes was diminished in cold
rystalloid cardioplegia  cyclosporine A myocardium (P  .05). Mitochondrial
esistance to calcium-mediated mitochondrial permeability transition pore opening
as not different in cold crystalloid cardioplegia and noncardiopulmonary bypass
itochondria, suggesting that calcium overload is not solely responsible for the
bserved deficits in mitochondrial function.
onclusions: Cyclosporine A pretreatment prevents postcardioplegia alterations in
itochondrial structure and function in a clinically relevant model of neonatal
ardiac surgery. Prevention of mitochondrial permeability transition pore opening
nd apoptosis signaling events (Bax translocation and mitochondrial permeabiliza-
ion) are associated with superior mitochondrial preservation.
 
he early postoperative period after neonatal cardiac surgery is notabl
myocardial dysfunction.1,2 Recent data indicate that apoptosis is indu
after cardioplegic arrest, suggesting a potential role for apoptosis in postop-
rative myocardial dysfunction.3,4 As a critical mediator in apoptosis signal
athways, mitochondria integrate upstream death stimuli and undergo structural and
unctional remodeling with subsequent transmission of signals to downstream
xecutioner proteins.5 We previously identified Bax translocation to the mitochon-
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CSPria, mitochondrial permeabilization, cytochrome c release,
nd deficits in mitochondrial Complex I function within 6
ours after cardioplegic arrest and reperfusion.6,7 Because
hese events occur in a time frame similar to that of post-
perative cardiac dysfunction, we hypothesized that apop-
osis-related mitochondrial dysfunction may contribute to
ostoperative myocardial dysfunction.6
The mitochondrial permeability transition pore (MPTP)
s a nonspecific pore that has been implicated as a potential
ediator of myocardial ischemic injury and initiation of
poptosis.8,9 Pharmacologic inhibition of MPTP opening
ssociated with myocardial protection against ischemic/
eperfusion injury.10,11 Cyclosporine A (CsA), which ac
y inhibiting the peptidyl-prolyl cis-trans isomerase activity
f CyP-D, is a specific inhibitor of MPTP opening, and the
rotective effects of CsA after ischemic injury have been
eported in a variety of in vitro12,13 and in vivo14 animal
odels of unprotected and protected15 ischemia. The poten-
ial for CsA-mediated MPTP inhibition to mitigate mito-
hondrial injury after cardioplegic arrest has rarely been
xplored in a large animal in vivo model. Therefore, the
urrent study was designed to examine the effect of CsA on
itochondrial injury and apoptosis signaling in a clinically
elevant model of neonatal cardioplegic arrest.
aterials and Methods
urgical Preparation
ewborn piglets (14 days) were anesthetized with intravenous
IV) sodium pentothal, intubated, and maintained with 1% isoflu-
ane. Cardiopulmonary bypass (CPB) was initiated with a blood
rime and passive cooling to 28°C to 30°C core temperature. The
orta was crossclamped, and cold antegrade crystalloid cardiople-
ia (Plegisol; Hospira, Inc, Lake Forest, Ill) (4°C, 50-70 mm Hg
erfusion pressure; 20 mL/kg followed by 15 mL/kg every 20
inutes) was administered. Topical cooling and aorta and pulmo-
ary artery venting were used. After 60 minutes, the crossclamp
as removed and the animal was rewarmed; after 10 to 20 min-
tes, CPB was terminated. General anesthesia was maintained for
hours. Arterial blood gases, electrolytes, and hematocrit were
aintained in a physiologic range. Inotropic agents were not
Abbreviations and Acronyms
CCP  cold crystalloid cardioplegia
COX IV cytochrome c oxidase IV
CPB  cardiopulmonary bypass
CsA  cyclosporine A
Ig  immunoglobulin
IV  intravenous
MPTP mitochondrial permeability transition pore
OCT  optimal cutting temperature
TUNEL  deoxyuride-5=-triphosphate biotin nick end
labelingdministered. f
24 The Journal of Thoracic and Cardiovascular Surgery ● JanuAfter 6 hours, the heart was quickly excised and perfused with
ce-cold phosphate-buffered saline. Left ventricular myocardium
as excised, snap-frozen in liquid nitrogen, and stored (80°C).
or mitochondrial oxygen consumption and cytochrome c release
easurements, myocardium was immediately fractionated as de-
cribed.6 Fresh mitochondrial fractions were used for oxy
onsumption measurements, mitochondrial calcium tolerance ex-
eriments, and electron microcopy. Myocardium was embedded in
ptimal cutting temperature (OCT) compound, frozen in liquid
itrogen, and stored at 80°C for apoptotic index assessment and
uorescent immunohistochemistry. Mitochondrial purity was con-
rmed by inspection of randomly chosen electron micrographs and
y porin concentrations and citrate synthase activity.
Comparison was made among the following groups: cold crys-
alloid cardioplegia (CCP, n  5); CCP with IV administration of
sA (10 mg/kg1; Novartis Pharmaceuticals Canada Inc, Dorval,
uebec)14 immediately before initiation of CPB (CCP  CsA,
 5); and non-CPB controls (n  5). For the non-CPB protocol,
fter anesthesia for 6 hours, a thoracotomy was performed and
yocardial tissue was harvested as described above.
All animals received humane care in compliance with the
Guide for the Care and Use of Laboratory Animals” prepared by
he Association for Assessment and Accreditation of Laboratory
nimal Care (March 1999), and approval was obtained from the
nimal Resource Committee at the Hospital for Sick Children.
lectron Microscopy
he mitochondrial fraction was resuspended and fixed with 2%
lutaraldehyde overnight. Mitochondria were postfixed, dehy-
rated, and embedded in Epon. Ultrathin sections were stained
ith lead citrate and uranyl acetate, and examined with a Hitachi
7000 (Hitachi High-Technologies Corp, Schaumburg, Ill) trans-
ission electron microscope at a magnification of 10,000.
itochondrial Fractionation for Biochemical Analysis
itochondrial fractionation was performed as described.6 Myo-
ardium samples were mechanically homogenized and lysed. Un-
ysed cells and nuclei were removed by centrifugation at 750g (5
inutes  2 at 4°C). The supernatant was spun at 8000g (25
inutes at 4°C), and the resulting mitochondrial pellets were
esuspended and frozen (80°C).
itochondrial Bax Translocation
ranslocation of Bax from cytosol to mitochondria was examined
y Western blot of mitochondrial protein fractions. Membranes
ere probed with anti-rabbit Bax (N-20, 1:1000; Santa Cruz Bio-
echnology, Inc, Santa Cruz, Calif). For protein loading control,
he membranes were stripped and reprobed with anti-mouse mito-
hondrial porin (1:20,000; Molecular Probes, Inc, Carlsbad, Calif).
econdary antibodies were coupled to horseradish peroxidase (anti-
abbit immunoglobulin [Ig]G 1:1000; anti-mouse IgG 1:10,000,
anta Cruz Biotechnology, Inc).
ytochrome c Release
itochondrial outer membrane permeability was evaluated by
easurement of cytochrome c release into the cytosol. After sub-
ellular fractionation, cardiac cytosolic samples were standardized
or protein concentration by a protein assay kit (Bio-Rad, Her-
ary 2008
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Pules, Calif), denatured, and subsequently transferred to nitrocel-
ulose membranes. The membrane was blocked with 5% nonfat
ilk and incubated overnight at 4°C with specific anti-mouse
ytochrome c (1:2000; BD Biosciences Pharmingen, San Diego,
alif). For protein loading control, membranes were stripped and
eprobed with anti-goat -actin (1:5,000; Santa Cruz Biotechnol-
gy, Inc). Secondary antibodies were coupled to horseradish per-
xidase (anti-mouse IgG 1:5,000; anti-goat IgG 1:10,000 Santa
ruz Biotechnology, Inc). Cytosolic cytochrome c was normalized
o -actin and cytosolic citrate synthase activity.3
luorescent Immunohistochemistry and
onfocal Imaging
CT-embedded transverse ventricular slices were cut into 5-m
erial sections fixed in acetone, and after blocking, mouse mono-
lonal anti-cytochrome c oxidase IV (COX IV) (1:250; BD Bio-
ciences Clonetech, Palo Alto, Calif) was used. Sections were
ncubated with secondary antibody (Cy3-conjugated donkey anti-
ouse IgG, 1:500; Jackson ImmunoResearch Laboratories, Inc,
est Grove, Pa). Mouse monoclonal anti-cytochrome c (1:200;
D Biosciences Pharmingen) was used as the primary antibody for
ytochrome c staining. Sections were immersed in secondary
ntibody (Cy2-conjugated donkey anti-mouse IgG, 1:200; Jackson
mmunoResearch Laboratories, Inc). The images from at least 3
ifferent sections were acquired at 64 by a Zeiss LSM510
ultiphoton Laser Scanning Cofocal Microscope (Carl Zeiss, Jena,
ermany), using the same pinhole setting, pixel format (1024 
024, and scanning data depth (0.8 m). Double fluorescence for
reen and red channels was imaged using excitation of Argon-
eNel at the wavelengths of 488 and 530 nm. Fifty high-power
elds from each animal were analyzed by imaging processing
oftware (Velocity 3.0, Improvision, Lexington, Mass). The high
ntensity of red and green (551 voxels) was regarded as specific
mmunoreactive signals. The red (COX IV) was set as the refer-
nce signal, and the contribution of the green (cytochrome c) to the
olocalization of the both signals was quantified as the overlap
oefficient (Kx-green) and used to compare the diffusion of cyto-
hrome c staining between groups.16
lark Electrode Oxygen Consumption Measurement
itochondrial Complex I, II, and IV respiration were measured by
he method of Ricci and colleagues17 using a Clark-type oxyge
lectrode (Instech Laboratories Inc, Plymouth Meeting, Pa). Oxy-
en consumption was measured in the presence of sequential
dministration of substrates and inhibitors (glutamate/malate for
omplex I, rotenone/succinate for Complex II, antimycin/tetramethyl-
-phenylenediamine/ascorbate for Complex IV) added in the fol-
owing order and final concentration: 2.5 mmol/L glutamate,
.5 mmol/L malate, 2 mmol/L adenosine diphosphate, 2 mol/L rote-
one, 5 mmol/L succinate, 1mol/L antimycin A, and 1 mmol/L ascor-
ate with 0.4 mmol/L N,N,N’N’-tetramethyl-p-phenylenediamine.
espiration rates are expressed as micromoles of molecular oxy-
en per milligram of mitochondrial protein.
eoxyuride-5=-Triphosphate Biotin Nick End
abeling Staining
CT-embedded transverse ventricular slices were cut into 10-merial sections that were used for deoxyuride-5=-triphosphate biotin c
The Journal of Thoracicick end labeling (TUNEL). TUNEL was performed with the In
itu Cell Death Detection Kit (Roche Diagnostics, Indianapolis,
nd) according to the manufacturer’s instructions. After TUNEL,
ll nuclei were counterstained with DAPI. The number of TUNEL-
ositive myocytes and the number of total myocytes were counted
n 25 random high-power fields (600) by a Leica (Deerfield, Ill)
uorescent microscope with OpenLab software (Improvision). Ap-
roximately 5000 myocytes were examined at least 3 different
ections from each animal.
itochondrial Calcium Tolerance: MPTP Opening
hreshold Experiments
itochondrial calcium tolerance experiments were determined by
a2-induced swelling of isolated cardiac mitochondria.18 Admin-
stration of exogenous calcium results in mitochondrial swelling,
hich is measured spectrophotometrically as a reduction in absor-
ance at 520 nm (A520). Isolated cardiac mitochondria were re-
uspended in a swelling buffer to a final protein concentration of
.22 mg/mL. Two picomoles of CaCl2 were added every minute,
nd the percentage of changes of absorbance at 520 nm was
ecorded. After sufficient Ca2 loading, an abrupt decrease in A520
bsorbance seems to be the result of MPTP opening. The amount
f Ca2 needed to trigger this change is an indicator of the
usceptibility of MPTP to Ca2 overload.19
tatistics
ata are expressed as mean  standard error of the mean, and
roup comparisons were made with Fisher’s least significant dif-
erence analysis of variance. A Tukey test was used for multiple
ost hoc comparisons.
esults
emodynamic Analysis
emodynamics (blood pressure, heart rate, central venous
ressure), blood gas, hemoglobin, and venous oxygen sat-
rations were monitored. At baseline, there were no differ-
nces between groups. During reperfusion, heart rate in the
CP group was increased at 1, 3, and 6 hours of reperfusion
ompared with the non-CPB group. Pretreatment with CsA
revented the heart rate increase. Arterial pH and base
xcess in the CCP group at 1 hour of reperfusion was
ecreased compared with the non-CPB group (7.30  0.04
nd 3.9  1.3 vs 7.42  0.02 and 0.9  0.5, respectively;
 .05). There were no differences in the value of pH and
ase excess between the non-CPB group and CCP  CsA
roups. Hemodynamic data are included in Table E1.
lectron Microscopy
epresentative electron microscopic images are shown in
igure 1. In contrast with the normal appearance of
itochondrial cristae in the non-CPB mitochondria, there is
xtensive disarrangement in cristal architecture with nar-
owing of the mitochondrial intermembrane space in the
CP mitochondria. Despite the pronounced alterations in
ristal architecture, the outer mitochondrial membranes ap-
and Cardiovascular Surgery ● Volume 135, Number 1 125
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CSPear to be intact. In contrast, the mitochondrial cristal ar-
hitecture was well preserved in the CCP  CsA group.
itochondrial Bax Translocation
itochondrial Bax content was greater in CCP myocardium
hen compared with that in the non-CPB and CCP  CsA
yocardium (0.78  0.08 AU vs 0.47  0.06 AU and 0.57
0.06 AU, P .01), which is consistent with translocation
f Bax from the cytosol to the mitochondria (Figure 2
itochondrial Permeabilization and
ytochrome c Release
ytosolic cytochrome c concentrations were higher in CCP
ompared with non-CPB and CCP  CsA myocardium
10.49  0.56 AU vs 7.16  0.61 AU and 7.33  0.4 AU,
espectively, P  .05; Figure 2). Citrate synthase activ
as not different between groups (0.1 0.1 mol1/mg1,26 The Journal of Thoracic and Cardiovascular Surgery ● Janu.1  0.2 mol1/mg1, and 0.09  0.1 mol1/mg1
rotein for non-CPB, CCP, and CCP  CsA, respectively).
Fluorescent immunohistochemistry was used to compare
he patterns of cytochrome c and COX IV staining (Figure A).
elease of cytochrome c from the mitochondria causes
iffusion of the cytochrome c staining in the cytoplasm, and
stippled green pattern is produced. This pattern is prom-
nent in the merged images from the CCP myocardium,
hereas in non-CPB and CCP  CSA myocardium, only
aint diffusion of cytochrome c staining in the merged
mages was found. The contribution of the green color
ntensity to the colocalization of these color voxels in the
erged images was quantified by overlap coefficients (Kx-
reen) (Figure 3. B). Compared with non-CPB and CCP
sA myocardium, lower overlap coefficient (Kx-green) was
ound in CCP myocardium (P  .01).
Figure 2. A, Representative Western
blot of mitochondrial Bax and cytoso-
lic cytochrome c in non-CPB, CCP, and
CCP  CsA hearts. B, Densitometric
measurements of Bax and cytochrome
c in non-CPB, CCP, and CCP  CsA
hearts. Increased concentrations of
Bax in the mitochondrial fractions nor-
malized by porin content are indicative
of translocation of Bax to the mito-
chondria. C, Higher concentrations of
cytochrome c in the cytosol standard-
ized by -actin and citrate synthase
activity are indicative of mitochondrial
permeabilization and release of cyto-
chrome c. **P< .01 and *P< .05 versus
non-CPB and #P < .05 versus CCP.
COX, Cytochrome c oxidase; CPB, car-
diopulmonary bypass; CCP, cold crystal-
Figure 1. Representative electron mi-
crographs of mitochondria isolated
from the non-CPB hearts (A), CCP
hearts (B), and CCP  CsA hearts (C)
(10,000). Compared with normal ul-
trastructure of mitochondria in non-
CPB, distortion of cristae and narrow-
ing of the intermembrane space were
observed in the CCP mitochondria.
Mitochondrial architecture was pre-
served in the CCP  CsA mitochondria.
COX, Cytochrome c oxidase; CPB, car-
diopulmonary bypass; CCP, cold crystal-
loid cardioplegia; CsA, cyclosporine A.loid cardioplegia; CsA, cyclosporine A.
ary 2008
Oka et al Cardiopulmonary Support and PhysiologyFigure 3. A, Immunofluorescence of
COX IV and cytochrome c in the myo-
cardium from non-CPB, CCP, and CCP 
CsA myocardium. In each panel, COX
IV (mitochondria) is stained red, cyto-
chrome c is stained green, and the
merged images are shown. Superimpo-
sition of red and green staining results
in a brownish color that suggests re-
tention of cytochrome c in the non-CPB
and CCP  CsA mitochondria. A fine
diffuse green staining can be seen in
the merged images of CCP myocar-
dium, suggesting mitochondrial re-
lease of cytochrome c. Scatterplots
display the intensity range of red and
green pixels in the merged images of
non-CPB, CCP, and CCP CsA, as well
as the various degrees of colocaliza-
tion shown in orange and yellow. B,
Quantification of the overlap coeffi-
cient (Kx-green) in the merged images
for non-CPB, CCP, and CCP  CsA
groups is shown. (*P < .01 vs non-CPB
and †P< .01 vs CCP). COX, Cytochrome
c oxidase; CPB, cardiopulmonary by-
pass; CCP, cold crystalloid cardiople-
gia; CsA, cyclosporine A.CS
PFigure 4. A, Apoptotic nuclei are shown
by TUNEL staining (green). B, Total nu-
clei were demarcated by DAPI staining
(blue). C, Apoptotic nuclei in the merged
image (arrows). D, Quantitative analysis
of TUNEL staining (*P < .01 vs non-CPB
and †P < .05 vs CCP). TUNEL, De-
oxyuride-5=-triphosphate biotin nick end
labeling; CPB, cardiopulmonary bypass;
CCP, cold crystalloid cardioplegia; CsA,
cyclosporine A.The Journal of Thoracic and Cardiovascular Surgery ● Volume 135, Number 1 127
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CSPlark Electrode Oxygen Consumption Measurements
solated mitochondrial oxygen consumption was assessed
uring state 2 respiration for mitochondrial Complexes I, II,
nd IV and was not different between groups, suggesting
omparable levels of mitochondrial integrity after fraction-
tion. Cardioplegic arrest was associated with diminished
tate 3 respiration at Complex I. The decrement in the ratio
f state 3 to state 2 respiration was prevented by pretreat-
ent with CsA (22.4  2.0, 11.8  2.0, and 25.9  1.9 for
on-CPB, CCP, and CCP  CsA, respectively, P  .01)
Table 1). Complex II and Complex IV oxygen consu
ion rates were not different.
UNEL Staining
UNEL-positive nuclei were more frequent in CCP myo-
ardium when compared with those in non-CPB and CsA
roups (1.7%  0.2% vs 0.1%  0.037% and 0.6% 
.1%, respectively; P  .01 and P  .05). There was no
tatistical difference in TUNEL-positive myocytes between
he non-CPB and CCP  CsA groups (Figure 4).
itochondrial Calcium Tolerance
he amount of Ca2 required to trigger MPTP opening of
itochondria was similar when comparing non-CPB and
CP mitochondria, suggesting that calcium overload is not
significant contributor to mitochondrial dysfunction 6
ours after cardioplegic arrest. CCP  CsA mitochondria
ere resistant to calcium-induced mitochondrial swelling,
uggesting that CsA inhibited MPTP opening to a
supranormal” level (eg, beyond the resistance associated
ith non-CPB mitochondria). The calcium required to trig-
er MPTP opening was 136.6 4.74 mol/L/mg vs 84.8
.48 mol/L/mg and 93.4  5.15 mol/L/mg protein for
CP  CsA, CCP, and non-CPB, respectively (P  .05).
iscussion
n the current study, postcardioplegic myocardium is asso-
iated with Bax translocation to the mitochondria, mito-
hondrial permeabilization, disarrangement of mitochon-
rial structure, release of cytochrome c into the cytoplasm,
nd a deficit of mitochondrial Complex I activity. Pretreat-
ent with CsA, an MPTP opening inhibitor, prevents these
hanges, suggesting that prevention of MPTP opening may
ABLE 1. Isolated mitochondrial oxygen consumption
Complex I
Non-CPB CCP CCP  CsA Non-CPB
tate 2 0.33 0.02 0.35 0.07 0.31 0.01 0.33 0.02
tate 3 7.39 0.63 3.72 0.60* 7.80 0.46† 2.52 0.19
atio 3/2 22.40 2.01 11.80 2.03* 25.20 1.91† 7.60 0.40
PB, Cardiopulmonary bypass; CCP, cold crystalloid cardioplegia; CsA, cyitigate the mitochondrial effects of cardioplegic arrest. C
28 The Journal of Thoracic and Cardiovascular Surgery ● JanuThe importance of these findings rests in the role of
itochondria as crucial cellular organelles controlling cell
ate, ion homeostasis, and energy production. During the
eperfusion period, mitochondrial structural and functional
emodeling is associated with transmission of death signals
eg, cytochrome c) to apoptosis executioner proteins.5 The
inkage between death stimuli and subsequent apoptosis is
rovided by multiple signaling pathways converging on the
itochondria, including Bcl-2 family proteins.20 Among the
cl-2 family of proteins, Bax is a known intermediate that
an initiate permeabilization of mitochondria21 through di-
ect pore-forming activity on the mitochondrial outer mem-
rane and is associated with inhibition of mitochondrial
espiratory chain activity.22,23 The translocation of Bax 
he current study is consistent with a role for Bax in the
itochondrial release of cytochrome c after cardioplegic
rrest.
In addition to triggering a postmitochondrial apoptotic
ascade, cytochrome c is an important component of mito-
hondrial oxidative phosphorylation. A relative deficiency
f mitochondrial cytochrome c has been reported to be
esponsible for deficits in mitochondrial respiratory chain
ctivity and may thereby contribute to deficits in myocardial
erformance.24 Therefore, a rationale is provided for a m-
reservation strategy focused on maintenance of mitochon-
rial structural and functional integrity.14,25 The MPTP is a
mportant mediator of mitochondrial integrity,26 and inhi-
ition of MPTP opening is associated with improved recov-
ry of cardiac function after ischemic injury.27 Conse-
uently, direct inhibition of MPTP opening with CsA may
rovide a valuable target for cardioprotection against
schemia/reperfusion injury.
In addition to MPTP inhibition, CsA also inhibits cal-
ineurin, which may alter intracellular calcium homeostasis
fter ischemia/reperfusion injury. It is important to rule out
ndirect protection of the mitochondria through alterations
n calcium handling. Calcineurin-mediated alterations in
ostreperfusion calcium loading are unlikely to be respon-
ible for the findings of the present study for 2 reasons.
irst, Nathan and colleagues,15 using FK506 (a specifi
alcineurin inhibitor) in a similar in vitro cardioplegia
odel, demonstrated that the myopreservation effect of
mplex II Complex IV
CCP CCP  CsA Non-CPB CCP CCP  CsA
5  0.07 0.31  0.01 0.33 0.02 0.35 0.07 0.31 0.01
3  0.19 2.28  0.30 10.10  0.41 7.55 0.93* 8.47 0.58
0  1.88 7.40  1.17 31.20  1.93 25.20 6.26 27.40 2.32
orine A. *P  .01 versus non-CPB. †P  .01 versus CCP.Co
0.3
2.1
7.2sA is independent of calcineurin. In addition, in the
ary 2008
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Present study, the calcium tolerance of mitochondrial MPTP
pening was assessed using incremental administration of
xtramitochondrial calcium. The nearly identical tolerance
f the CCP and non-CPB mitochondria suggests that post-
ardioplegia alterations in mitochondrial structure and func-
ion are not the result of calcineurin-mediated alterations in
alcium loading of the mitochondria at 6 hours of reperfu-
ion. The greater calcium tolerance of the CsA-treated mi-
ochondria suggests that CsA inhibits MPTP opening after
ardioplegic arrest. It is possible, however, that elevated
ytosolic calcium concentrations earlier in the postoperative
eriod (eg, 6 hours of reperfusion) may have played an
mportant role in the observed alterations in mitochondrial
tructure and function.
The precise mechanism whereby cytochrome c is re-
eased across the outer mitochondrial membrane in the
urrent study is not certain. MPTP opening has been de-
cribed as occurring in 1 of 2 modes: transient and long-
asting, the latter is often irreversible.9 Because the surfac
rea of the inner mitochondrial membrane exceeds that of
he outer membrane, extensive matrix swelling with long-
asting MPTP opening can lead to the unfolding of cristae
ithin the inner mitochondrial membrane, causing the outer
embrane to rupture with irreversible release of cyto-
hrome c.27 This mechanism does not appear to be pre
n the current study because the electron microscopy data
emonstrated mitochondria in the CCP group that are highly
emodeled in terms of cristal architecture but with little
vidence of mitochondrial swelling or rupture of the outer
itochondrial membranes. In addition, citrate synthase ac-
ivity was not increased in the CCP groups, suggesting that
he structural integrity of the outer mitochondrial membrane
as maintained in the CCP mitochondria. Therefore, if
PTP opening is the mechanism of cytochrome c release in
he current study, a transient opening is more likely to be
resent than a long-lasting or permanent opening.
Another possible mechanism of cytochrome c release in
he current study is direct Bax-mediated mitochondrial
embrane permeabilization.28 Bax can directly interac
ith MPTP to regulate cytochrome c release29,30 without
ny apparent loss of mitochondrial membrane potential.31 In
he current study, Bax translocation to the mitochondrial
raction was inhibited by CsA. Because transient MPTP
pening has been demonstrated to contribute a feedforward
ignal to amplify Bax translocation to the mitochondri32
he current data are consistent with CsA-mediated inhibition
f this amplification step. Therefore, at least 2 possible
echanisms for cytochrome c release are consistent with
he presented data: MPTP opening (and cytochrome c re-
ease) may be independent of Bax participation or MPTP
pening may promote Bax translocation with subsequent
ax-mediated feedforward augmentation of mitochondrial
ermeabilization.
The Journal of Thoraciconclusions
he current data suggest that MPTP-mediated alterations in
itochondrial structure and function are present after car-
ioplegic arrest and that inhibition of MPTP opening with
sA can ameliorate these changes. The “action” is focused
t the level of the mitochondria, where postreperfusion cell
urvival, apoptosis, and necrosis signals are adjudicated,
ell fate is determined, and energy for myocyte performance
s generated. Better understanding of the cardinal role of
itochondria at the convergence point of these vital path-
ays will enhance myopreservation strategies for the car-
iac surgeon.
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Pable E1. Hemodynamics and blood gas in piglet model of cardioplegic arrest
Baseline 1-h Reperfusion
Sham CCP CsA Sham CCP CsA
R (beats/min) 115 10.9 122 6.8 124 6.1 115 10.5 151 12.8* 112 6.1†
BP (mm Hg) 65 3.6 60 4.0 66 1.9 59 4.5 57  1.2 59 4.8
BP (mm Hg) 40 1.6 36 3.9 42 0.9 37 3.1 31  2.4 31 2.8‡
VP (mm Hg) 7.2 0.6 5.2 0.8 6.2 0.7 7.2 0.5 6.6 0.7 6.6 1.1
ody temperature (°C) 37 0.0 38 0.5 38 0.3 37 0.1 37  0.8 37 0.3
(mmol/L) 4.0 0.2 3.9 0.1 3.6 0.2 4.7 0.3 3.7 0.2* 3.6 0.2*
a (mmol/L) 1.4 0.0 1.2 0.1 1.3 0.1 1.5 0.0 1.4 0.1 1.3 0.0*
Hb (g/dL) 9.4 0.3 10.1 0.4 9.3  0.7 9.7 0.6 10.5 0.8 12.0 1.0
H 7.49 0.02 7.49 0.04 7.50 0.04 7.42 0.02‡ 7.30 0.04*‡ 7.36 0.02‡
O2 (mm Hg) 516 9.7 493 20 503 26 435 53.6 272 70‡ 281 88‡
CO2 (mm Hg) 34  2.3 34 3.4 29 4.1 39 1.6 47  3.6‡ 42 3.3
CO3 (mmol/L) 26  0.5 25 1.3 24 1.7 25 0.6 22  0.8*‡ 23 1.2
E (mmol/L) 3.1 0.3 2.2 1.2 1.8 1.3 0.9 0.5‡ 3.9  1.3*‡ 1.6  0.9
AO2 (%) 100 0.0 100 0.0 100 0.4 100 0.0 98 1.8 100 0.0
VO2 (%) 86  1.0 82 2.5 83 4.0 68 2.1‡ 55 9.7‡ 60 6.4‡
R, Heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; CVP, central venous blood pressure; tHb, total hemoglobin; BE, base excess;
AO2, arterial oxygen saturation; SVO2, venous oxygen saturation in non-CPB, CCP, and CCP  CsA-treated piglets. *P  .05 versus non-CPB at the same
ime point. †P  .05 versus CCP at same time point. ‡P  .05 versus non-CPB at baseline.The Journal of Thoracic and Cardiovascular Surgery ● Volume 135, Number 1 130.e1
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CSPABLE E1. Continued
3-h Reperfusion 6-h Reperfusion
Sham CCP CsA Sham CCP CsA
117 9.3 130 14.5* 112 10.9† 125 8.0 152 9.8* 115  11.4†
52  4.1‡ 54 2.2 54 4.3‡ 53 3.4 54 3.4 58  3.8
31  2.3‡ 28 3.4 32 2.8‡ 26 1.8‡ 25 2.3 30  5.2‡
7.8  0.4 6.8 0.7 6.8 1.2 8.0  0.4 6.6 0.8 7.0  1.2
37  0.2 37 0.7 37  0.4 37 0.2 37 0.6 37  0.5
5.0  0.2‡ 4.1 0.3* 4.4 0.2‡ 6.1  0.3‡ 4.9 0.5*‡ 4.5  0.2*‡
1.3  0.0 1.4 0.1 1.4 0.1 1.4  0.1 1.4 0.1 1.3  0.0
9.3  0.8 10.9 1.2 13.5 1.1*‡ 9.0 0.7 10.9 1.2 14.3  1.5*‡
.44 0.02‡ 7.41 0.03 7.40 0.01‡ 7.42 0.02‡ 7.43 0.03 7.42  0.02‡
474 9.7 340 73.9 289 76.3‡ 474 18.5 349.4 78.9 444  33.5
34  1.6 41 3.9 50 11.2‡ 39 2.2 40 3.4 35  1.3
23  0.6‡ 25 0.9 23 1.6 25 0.7 26 0.5 23  1.5
0.2  1.0‡ 1.1 0.4 1.0  1.4 1.0  0.7‡ 2.4  0.80 0.76  1.2
100 0.0 97  2.8 99 1.2 100 0.0 97  2.8 100  0.0
60  2.3‡ 48 7.0‡ 45 7.2‡ 55 3.1‡ 52 11‡ 47  8.6‡30.e2 The Journal of Thoracic and Cardiovascular Surgery ● January 2008
